D2 receptor-mediated inhibition of dopamine release in the rat striatum in vitro is modulated by CB1 receptors: Studies using fast cyclic voltammetry

Journal of Neurochemistry

Volumn 108, Issue 3, 2009, Pages 545-551

  O'Neill, Carmel ^a   Evers Donnelly, Alex ^a   Nicholson, David ^a   O'Boyle, Kathy M ^a   O'Connor, John J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cannabinoid1 receptors; Dopamine release; Dopamine2 receptors; Fast cyclic voltammetry; Striatum; WIN55212 2

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; AUTORECEPTOR; CANNABINOID 1 RECEPTOR; CARBON FIBER; DOPAMINE 2 RECEPTOR; QUINPIROLE; BENZOXAZINE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LIGAND; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; IN VITRO STUDY; MALE; MICROELECTRODE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTROCHEMISTRY; METABOLISM; NEOSTRIATUM; PHYSIOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; BENZOXAZINES; DOPAMINE; DOPAMINE AGONISTS; ELECTROCHEMISTRY; LIGANDS; MORPHOLINES; NAPHTHALENES; NEOSTRIATUM; PIPERIDINES; PYRAZOLES; QUINPIROLE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D2;

EID: 58149357089     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05782.x     Document Type: Article

References (38)

1. Armstrong-James M. Millar J. (1979) Carbon fibre microelectrodes. J. Neurosci. Methods 1, 279 287.
2. Blandini F., Nappi G., Tassorelli C. Martignoni E. (2000) Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol. 62, 63 88.
3. Bull D. R., Palij P., Sheehan M. J., Millar J., Stamford J. A., Kruk Z. L. Humphrey P. P. (1990) Application of fast cyclic voltammetry to measurement of electrically evoked dopamine overflow from brain slices in vitro. J. Neurosci. Methods 32, 37 44.
4. Cadogan A. K., Alexander S. P., Boyd E. A. Kendall D. A. (1997) Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum. J. Neurochem. 69, 1131 1137.
5. Cheer J. F., Wassum K. M., Sombers L. A., Heien M. L., Ariansen J. L., Aragona B. J., Phillips P. E. Wightman R. M. (2007) Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 27, 791 795.
6. Fernandez-Ruiz J. Gonzales S. (2005) Cannabinoid control of motor function at the basal ganglia. Handb. Exp. Pharmacol., 168, 479 507.
7. Freund T. F., Katona I. Piomelli D. (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017 1066.
8. Fuxe K., Marcellino D., Rivera A. et al. (2008) Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58, 415 452.
9. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., de Costa B. R. Rice K. C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563 583.
10. Hermann H., Marsicano G. Lutz B. (2002) Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109, 451 460.
11. Kathmann M., Bauer U., Schlicker E. Gothert M. (1999) Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Naunyn Schmiedebergs Arch. Pharmacol. 359, 466 470.
12. Kearn C. S., Blake-Palmer K., Daniel E., Mackie K. Glass M. (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 67, 1697 1704.
13. Kruk Z. L. O'Connor J. J. (1995) Fast electrochemical studies in isolated tissues. Trends Pharmacol. Sci. 16, 145 149.
14. Lau T. Schloss P. (2008) The cannabinoid CB1 receptor is expressed on serotonergic and dopaminergic neurons. Eur. J. Pharmacol. 578, 137 141.
15. Ledent C., Valverde O., Cossu G. et al. (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401 404.
16. Limberger N., Trout S. J., Kruk Z. L. Starke K. (1991) "Real time" measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 344, 623 629.
17. Marcellino D., Carriba P., Filip M. et al. (2008) Antagonistic cannabinoid CB(1)/dopamine D(2) receptor interactions in striatal CB(1)/D(2) heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology 54, 815 823.
18. Martin A. B., Fernandez-Espejo E., Ferrer B., Gorriti M. A., Bilbao A., Navarro M., Rodriguez de Fonseca F. Moratalla R. (2008) Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. Neuropsychopharmacology 33, 1667 1679.
19. Matsuda L. A. (1997) Molecular aspects of cannabinoid receptors. Crit. Rev. Neurobiol. 11, 143 166.
20. Matsuda L. A., Bonner T. I. Lolait S. J. (1992) Cannabinoid receptors: which cells, where, how, and why? NIDA Res. Monogr. 126, 48 56.
21. McDonald R. J. Hong N. S. (2004) A dissociation of dorso-lateral striatum and amygdala function on the same stimulus-response habit task. Neuroscience 124, 507 513.
22. Meschler J. P. Howlett A. C. (2001) Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 40, 918 926.
23. Millar J. Barnett T. G. (1988) Basic instrumentation for fast cyclic voltammetry. J. Neurosci. Methods 25, 91 95.
24. Moore T. H., Zammit S., Lingford-Hughes A., Barnes T. R., Jones P. B., Burke M. Lewis G. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319 328.
25. Moreno M., Lopez-Moreno J. A., Rodriguez de Fonseca F. Navarro M. (2005) Behavioural effects of quinpirole following withdrawal of chronic treatment with the CB1 agonist, HU-210, in rats. Behav. Pharmacol. 16, 441 446.
26. O'Neill C. O'Connor J. J. (2008) An investigation into the influence of NMDA and GABA on the modulation of electrically stimulated dopamine release by adenosine in the rat striatum: studies using fast cyclic voltammetry. Sensors 8, 5229 5237.
27. O'Neill C., Nolan B. J., Macari A., O'Boyle K. M. O'Connor J. J. (2007) Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors. Eur. J. Neurosci. 26, 3421 3428.
28. Pearson Z. S. Rice M. E. (2004) Cannabinoid receptors modulate dopamine release in guinea pig dorsal and ventral striatum. Neuroscience 953, 4.
29. Pertwee R. G. (2006) The pharmacology of cannabinoid receptors and their ligands: an overview. Int. J. Obes. (Lond) 30 (Suppl. 1 S13 S18.
30. Price D. A., Owens W. A., Gould G. G., Frazer A., Roberts J. L., Daws L. C. Giuffrida A. (2007) CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J. Neurochem. 101, 389 396.
31. Rodriguez de Fonseca F., Del Arco I., Martin-Calderon J. L., Gorriti M. A. Navarro M. (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol. Dis. 5, 483 501.
32. Schlicker E. Kathmann M. (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22, 565 572.
33. 2, and KATP channels. Neurochem. Int. 52, 80 88.
34. van der Stelt M. Di Marzo V. (2003) The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol. 480, 133 150.
35. Szabo B. Schlicker E. (2005) Effects of cannabinoids on neurotransmission. Handb. Exp. Pharmacol. 168, 327 365.
36. Szabo B., Muller T. Koch H. (1999) Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J. Neurochem. 73, 1084 1089.
37. Twitchell W., Brown S. Mackie K. (1997) Cannabinoids inhibit N-and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78, 43 50.
38. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M. Watanabe M. (2007) Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27, 3663 3676.